Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Vildagliptin

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Vildagliptin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 388Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Equa/EquMet

    02 6Galvus

    03 5Galvus Group

    04 2Glumetza

    05 5Janumet

    06 3Trajenta/ Jentadueto

    07 2Trajenta/Jentadueto

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Trajenta/ Jentadueto

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Trajenta/ Jentadueto

    Germany
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Boehringer Ingelheim

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 1,801

    2019 Revenue in Millions : 1,857

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Equa/EquMet

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Equa/EquMet

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Dainippon Sumitomo

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 391

    2019 Revenue in Millions : 75

    Growth (%) : 421

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Galvus Group

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Galvus Group

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 1,199

    2019 Revenue in Millions : 1,297

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Janumet

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Janumet

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Merck

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 1,971

    2019 Revenue in Millions : 2,041

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Trajenta/ Jentadueto

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Trajenta/ Jentadueto

    Germany
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Boehringer Ingelheim

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 1,709

    2020 Revenue in Millions : 1,801

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Janumet

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Janumet

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Merck

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 1,964

    2020 Revenue in Millions : 1,971

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Equa/EquMet

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Equa/EquMet

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Dainippon Sumitomo

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 322

    2020 Revenue in Millions : 391

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Galvus Group

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Galvus Group

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 1,092

    2020 Revenue in Millions : 1,199

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Janumet

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Janumet

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Merck & Co.

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 1,700

    2021 Revenue in Millions : 1,964

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Trajenta/Jentadueto

    Vildagliptin, Metformin Hydrochloride

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Trajenta/Jentadueto

    Germany
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Boehringer Ingelheim

    Vildagliptin, Metformin Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 1,846

    2021 Revenue in Millions : 1,709

    Growth (%) : 8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.